Pancreatic Cancer Research

ResearcherMoffitt Cancer CenterActive in the last 2 years

Robert J. Gillies

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-8888-7747; OpenAlex author ID A5082346230; NIH RePORTER profile ID 1858946. Sources: OpenAlex.

Their work

Papers
7 (first author 0, last author 4)
Trials
0
Grants
2
Labs led
1
Collaborators
28
Papers, trials and grants by year

2011: 1 paper · 2012: none · 2013: 1 paper · 2014: 1 paper · 2015: 1 paper · 2016: 1 paper · 2017: none · 2018: 1 grant · 2019: none · 2020: none · 2021: 1 paper · 2022: none · 2023: none · 2024: 1 paper, 1 grant

Papers 7

  1. L-DOS47 Elevates Pancreatic Cancer Tumor pH and Enhances Response to Immunotherapy. Last author DOI 10.3390/biomedicines12020461↗
  2. Delta radiomics analysis of Magnetic Resonance guided radiotherapy imaging data can enable treatment response prediction in pancreatic cancer. Last author DOI 10.1186/s13014-021-01957-5↗
  3. MR Imaging Biomarkers to Monitor Early Response to Hypoxia-Activated Prodrug TH-302 in Pancreatic Cancer Xenografts. Last author DOI 10.1371/journal.pone.0155289↗
  4. Therapeutic Targeting of the Warburg Effect in Pancreatic Cancer Relies on an Absence of p53 Function. Co-author DOI 10.1158/0008-5472.can-15-0108↗
  5. Evaluation of the "steal" phenomenon on the efficacy of hypoxia activated prodrug TH-302 in pancreatic cancer. Last author DOI 10.1371/journal.pone.0113586↗
  6. Synthesis and evaluation of cholecystokinin trimers: a multivalent approach to pancreatic cancer detection and treatment. Co-author DOI 10.1016/j.bmcl.2013.02.022↗
  7. Development of an orthotopic human pancreatic cancer xenograft model using ultrasound guided injection of cells. Co-author DOI 10.1371/journal.pone.0020330↗

Grants 2

  1. Imaging Acidosis and Immune Therapy in PDAC R01CA239219↗
  2. Causes & Consequences of Acid pH in Tumors R01CA077575↗

Closest collaborators

The 25 strongest of 28 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Shari Pilon-Thomas · 1 shared paper, 1 shared grant, 2024 · strength 0.89
  2. Arig A Ibrahim Hashim · 1 shared grant, 2024 · strength 0.72
  3. Bruna Victorasso Jardim‐Perassi · 1 shared paper, 2024 · strength 0.16
  4. Barbara Ann Centeno · 1 shared paper, 2024 · strength 0.16
  5. Russell F. Palm · 1 shared paper, 2021 · strength 0.13
  6. Jessica M. Frakes · 1 shared paper, 2021 · strength 0.13
  7. Michal R. Tomaszewski · 1 shared paper, 2021 · strength 0.13
  8. Sarah E. Hoffe · 1 shared paper, 2021 · strength 0.13
  9. Pawel Swietach · 2 shared papers, 2014–2016 · strength 0.11
  10. Amanda F. Baker · 2 shared papers, 2014–2016 · strength 0.11
  11. Charles P. Hart · 2 shared papers, 2014–2016 · strength 0.11
  12. Xiaomeng Zhang · 1 shared paper, 2016 · strength 0.07
  13. Anne Le · 1 shared paper, 2015 · strength 0.04
  14. Shinichi Yabuuchi · 1 shared paper, 2015 · strength 0.04
  15. N.V. Rajeshkumar · 1 shared paper, 2015 · strength 0.04
  16. Jurre J. Kamphorst · 1 shared paper, 2015 · strength 0.04
  17. Prasanta Dutta · 1 shared paper, 2015 · strength 0.04
  18. Roeland F. de Wilde · 1 shared paper, 2015 · strength 0.04
  19. Manuel M. Hidalgo · 1 shared paper, 2015 · strength 0.04
  20. Joshua D. Rabinowitz · 1 shared paper, 2015 · strength 0.04
  21. Anirban Maitra · 1 shared paper, 2015 · strength 0.04
  22. Chi Van Dang · 1 shared paper, 2015 · strength 0.04
  23. Kate M. Bailey · 1 shared paper, 2014 · strength 0.04
  24. Xiaomeng Zhang · 1 shared paper, 2014 · strength 0.04
  25. Nabila Brabez · 1 shared paper, 2013 · strength 0.03

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.